|
1AO8
DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE, NMR, 21 STRUCTURES
提交 1997-07-22
|
配体/离子不同
实验环境不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–162(162 aa)
|
未记录
|
MTX METHOTREXATE × 1
|
SOLUTION NMR
NMR测量条件
pH 6.5;308 K;离子强度(mmCIF原始值)150 mM
|
分辨率未提供
|
|
1BZF
NMR SOLUTION STRUCTURE AND DYNAMICS OF THE COMPLEX OF LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE WITH THE NEW LIPOPHILIC ANTIFOLATE DRUG TRIMETREXATE, 22 STRUCTURES
提交 1998-10-28
|
配体/离子不同
实验环境不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–162(162 aa)
|
未记录
|
TMQ TRIMETREXATE × 1
|
SOLUTION NMR
NMR测量条件
pH 6.5;308 K;离子强度(mmCIF原始值)550 mM;压力 1
NMR样品组成
90% H2O/10% D2O, 100% D2O
|
分辨率未提供
|
|
1DIS
DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEX WITH BRODIMOPRIM-4,6-DICARBOXYLATE
提交 1995-08-01
|
配体/离子不同
实验环境不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–162(162 aa)
|
未记录
|
BDM BRODIMOPRIM-4,6-DICARBOXYLATE × 1
|
SOLUTION NMR
mmCIF 未提供已读取条件
|
分辨率未提供
|
|
1DIU
DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEX WITH BRODIMOPRIM-4,6-DICARBOXYLATE
提交 1995-08-01
|
配体/离子不同
实验环境不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–162(162 aa)
|
未记录
|
BDM BRODIMOPRIM-4,6-DICARBOXYLATE × 1
|
SOLUTION NMR
mmCIF 未提供已读取条件
|
分辨率未提供
|
|
2HM9
Solution structure of dihydrofolate reductase complexed with trimethoprim, 33 structures
提交 2006-07-11
|
配体/离子不同
实验环境不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–162(162 aa)
|
未记录
|
TRR 2,4-DIAMINO-5-(3,4,5-TRIMETHOXY-BENZYL)-PYRIMIDIN-1-IUM × 1
|
SOLUTION NMR
NMR测量条件
pH 6.5;308 K;离子强度(mmCIF原始值)100mM KCl;压力 ambient
NMR样品组成
0.5mM DHFR-15N/TMP, 50mM phosphate buffer, 5% DMPC/DHPC (3:1), 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR样品组成
1mM DHFR-15N/TMP, 50mM phosphate buffer, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR样品组成
1mM DHFR-15N/TMP, 50mM phosphate buffer, 100% D2O | 100% D2O
|
分辨率未提供
|
|
2HQP
Solution structure of L.casei dihydrofolate reductase complexed with NADPH, 32 structures
提交 2006-07-19
|
配体/离子不同
实验环境不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–162(162 aa)
|
未记录
|
NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE × 1
|
SOLUTION NMR
NMR测量条件
pH 6.5;308 K;离子强度(mmCIF原始值)100mM KCl;压力 ambient
NMR样品组成
0.5mM DHFR-15N/NADPH, 50mM phosphate buffer, 5% DMPC/DHPC, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR样品组成
1mM DHFR-15N/NADPH, 50mM phosphate buffer, 100% H2O | 100% H2O
NMR样品组成
1mM DHFR-15N/NADPH, 50mM phosphate buffer, 90% H2O, 10% D2O | 90% H2O/10% D2O
|
分辨率未提供
|
|
2L28
Solution structure of lactobacillus casei dihydrofolate reductase apo-form, 25 conformers
提交 2010-08-13
|
构建体不同
配体/离子不同
实验环境不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
2–163(162 aa)
|
未记录
|
未记录非水小分子
|
SOLUTION NMR
NMR测量条件
pH 6.5;288 K;离子强度(mmCIF原始值)100;压力 ambient
NMR样品组成
2 mM entity-1, 100 mM potassium chloride-2, 50 mM potassium phosphate-3, 0.1 % sodium azide-4, 100% D2O | 100% D2O
NMR样品组成
1 mM [U-99% 13C; U-99% 15N] entity-5, 100 mM potassium chloride-6, 50 mM potassium phosphate-7, 0.1 % sodium azide-8, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成
1 mM [U-99% 15N] entity-9, 100 mM potassium chloride-10, 50 mM potassium phosphate-11, 0.1 % sodium azide-12, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成
1 mM [U-99% 15N] entity-13, 100 mM potassium chloride-14, 50 mM potassium phosphate-15, 0.1 % sodium azide-16, 5 % DMPC/DHPC-17, 95% H2O/5% D2O | 95% H2O/5% D2O
|
分辨率未提供
|
|
2LF1
Solution structure of L. casei dihydrofolate reductase complexed with NADPH, 30 structures
提交 2011-06-28
|
构建体不同
配体/离子不同
实验环境不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
2–163(162 aa)
|
未记录
|
NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE × 1
|
SOLUTION NMR
NMR测量条件
pH 6.5;308 K;离子强度(mmCIF原始值)100;压力 ambient
NMR测量条件
pH 6.5;288 K;离子强度(mmCIF原始值)100;压力 ambient
NMR样品组成
2 mM [U-99% 13C; U-99% 15N] DHFR, 2 mM NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, 100 mM potassium chloride, 50 mM potassium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成
2 mM [U-99% 13C; U-99% 15N] DHFR, 2 mM NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, 100 mM potassium chloride, 50 mM potassium phosphate, 100% D2O | 100% D2O
NMR样品组成
2 mM [U-99% 15N] DHFR, 2 mM NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, 100 mM potassium chloride, 50 mM potassium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成
4 mM DHFR, 4 mM NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, 100 mM potassium chloride, 50 mM potassium phosphate, 100% D2O | 100% D2O
NMR样品组成
1 mM [U-99% 15N] DHFR, 1 mM NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, 100 mM potassium chloride, 50 mM potassium phosphate, 5 v/v n-octylpenta-ethylene glycol (C8E5), 1.5 v/v n-octanol, 95% H2O/5% D2O | 95% H2O/5% D2O
|
分辨率未提供
|
|
3DFR
CRYSTAL STRUCTURES OF ESCHERICHIA COLI AND LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE REFINED AT 1.7 ANGSTROMS RESOLUTION. I. GENERAL FEATURES AND BINDING OF METHOTREXATE
提交 1982-06-25
|
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–162(162 aa)
|
未记录
|
NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE × 1
MTX METHOTREXATE × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 1.70 Å
|